| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |